Bristol-Myers Squibb

Approval Status
Approved August 1997

Treatment for
Kaposi's Sarcoma

Immune System , Cancer & Oncology

The U.S. Food and Drug Administration approved Bristol-Myers Squibb's cancer drug Taxol for the treatment of AIDS-related Kaposi's Sarcoma. Taxol therapy reduces the size of patients' tumors and diminishes their symptoms and pain. Taxol helped a majority of patients who had failed other therapies.

Taxol Drug Information

The Taxol drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top